Guidance

Medicines eligible for Northern Ireland MHRA Authorised Route

Sets out medicines that can be moved to Northern Ireland to meet patient need.

Documents

List of medicines that can be moved through NIMAR

Details

This document lists the medicines eligible for supply through the Northern Ireland MHRA Authorised Route (NIMAR).

From 1 January 2022, the listed medicines may be dispatched from Great Britain to Northern Ireland on the basis of the medicine’s authorisation in Great Britain.

This list is maintained and published in accordance with regulation 167B (list of NIMAR products) of the Human Medicines Regulations 2012 (SI 2012/1916, as amended).

Published 16 December 2021
Last updated 38 August 2022 + show all updates
  1. Added the following to the list of medicines that can be moved through NIMAR: Amlodipine/Valsartan 10mg/160mg, Amlodipine/Valsartan 5mg/160mg, Amlodipine/Valsartan 5mg/80gm, Fluorouracil 2.5g/100ml solution for infusion vials, Palbociclib 100mg tablets, Palbociclib 125mg tablets, Palbociclib 75mg tablets, Fluenz Tetra vaccine nasal suspension 0.2ml unit dose, Flucelvax Tetra vaccine suspension for injection 0.5ml pre-filled syringes, Ozempic 0.5mg/0.37ml solution for injection 1.5ml pre-filled pens, Imvanex vaccine suspension for injection 0.5ml vials, Metalyse 10,000unit powder and solvent for solution for injection vials, Topotecan 4mg powder for solution for infusion vials.

  2. Added the following to the list: Bevacizumab 100mg/4ml solution for infusion vials, Ceritinib 150mg tablets, Enbrel paediatric 10mg powder and solvent for injection vials, Estradiol valerate 1mg / Medroxyprogesterone 2.5mg tablets, Estradiol valerate 2mg / Medroxyprogesterone 5mg tablets, Etanercept 10mg powder and solvent for injection vials, Ibrance 75mg capsules, Ibrance 100mg capsules, Ibrance 125mg capsules, Indivina 1mg/2.5mg tablets, Indivina 2mg/5mg tablets, Kisqali 200mg tablets, Lapatinib 250mg tablets, Palbociclib 75mg capsules, Palbociclib 100mg capsules, Palbociclib 125 mg capsules, Pegvisomant 20mg powder and solvent for solution for injection vials, Ribociclib 200mg tablets , Somavert 20mg powder and solvent for solution for injection vials, Tyverb 250mg tablets (84 tablet), Zirabev 100mg/4ml solution for infusion vials and Zykadia 150mg tablets.

  3. Added to the list: Onpattro 2 mg/mL concentrate for solution for infusion; Patisiran 2 mg/mL concentrate for solution for infusion.

  4. Added Everolimus 3mg dispersible tablets sugar free, Nilotinib 150mg capsules, Pazopanib 200mg tablets, and Pazopanib 400mg tablets.

  5. Updated to remove Glucagon 0.5mg solution for injection in pre-filled pen from the list.

  6. Added Silver Sulfadiazine Cream 1%, Glucagon 0.5mg solution for injection in pre-filled pen, Glucagon 1mg solution for injection in pre-filled pen. Removed Estradiol 0.06% gel (750microgram per actuation).

  7. Replaced spreadsheet with updated version with the following listing: 'Fondaparinux sodium 7.5mg/0.6ml solution for injection, pre-filled syringe'.

  8. Added fondaparinux 5mg, 7mg and 10mg to the list of medicines that can be moved through NIMAR.

  9. Added bexarotene 75mg capsules to and removed eltrombopag 75mg capsules and thiopental from the list of medicines that can be moved through NIMAR.

  10. Replaced spreadsheet with updated version listing Buccolam as the brand name for Midazolam.

  11. Added Acetylcysteine, Canagliflozin, Eltrombopag, Estradiol, Insulin isophane, Midazolam, Progesterone and Topotecan to the list of medicines that can be moved through NIMAR.

  12. Added Etanercept 50mg/1ml, Somatropin (rbe) (5mg/1.5ml, 10mg/1.5ml, 15mg/1.5ml) and Thiopental 500mg powder to the list of medicines that can be moved through NIMAR.

  13. Added 'Cobimetinib 20mg tablets' to the list of medicines that can be moved through NIMAR.

  14. Added 2 new lines to the list: sodium chloride 0.18% + glucose 4% infusion bags and sucralfate 1g/5ml liquid.

  15. First published.